← Open Payments lookup

ERIC AMENE: Open Payments

NPI 1750641221 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$766 in 32 payments from 9 companies in 2025. Trend: 2023 $1,233 · 2024 $340 · 2025 $766

Food & beverage: $766
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$203
ABBVIE INC.8$144
E.R. Squibb & Sons, L.L.C.2$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$75
Neurocrine BioSciences, Inc.3$70
Vanda Pharmaceuticals Inc.2$52
Axsome Therapeutics, Inc.2$34
Janssen Pharmaceuticals, Inc1$26
Alkermes, Inc.1$20

Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, INGREZZA, ABILIFY ASIMTUFII, HETLIOZ, Auvelity.

Industry payments across MD — which companies pay providers there.